Fortis Malar (FORTISMLR) | Financial Analysis & Statements
Fortis Malar Hospitals Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
205.0K
Gross Profit
205.0K
100.00%
Operating Income
42.8M
20,901.95%
Net Income
41.5M
20,257.07%
EPS (Diluted)
₹2.22
Balance Sheet Metrics
Total Assets
368.3M
Total Liabilities
66.2M
Shareholders Equity
302.1M
Debt to Equity
0.22
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Fortis Malar Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 588.5M | 858.1M | 860.7M | 691.2M |
| Cost of Goods Sold | 0 | 87.7M | 126.6M | 170.2M | 140.6M |
| Gross Profit | 0 | 500.8M | 731.5M | 690.4M | 550.6M |
| Gross Margin % | 0.0% | 85.1% | 85.2% | 80.2% | 79.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 12.1M | 201.8M | 274.8M | 272.9M | 241.1M |
| Other Operating Expenses | 142.0K | 142.7M | 198.8M | 183.9M | 175.7M |
| Total Operating Expenses | 12.3M | 344.5M | 473.6M | 456.8M | 416.8M |
| Operating Income | -21.4M | -104.0M | -73.1M | -90.9M | -192.1M |
| Operating Margin % | 0.0% | -17.7% | -8.5% | -10.6% | -27.8% |
| Non-Operating Items | |||||
| Interest Income | 25.0M | 55.9M | 62.8M | 70.6M | 71.4M |
| Interest Expense | 102.0K | 43.0M | 60.7M | 65.6M | 72.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 5.7M | 500.1M | -70.1M | -82.6M | -113.1M |
| Income Tax | 1.8M | 46.8M | 84.7M | 122.0K | -34.4M |
| Effective Tax Rate % | 31.0% | 9.4% | 0.0% | 0.0% | 0.0% |
| Net Income | 3.9M | 453.2M | -154.8M | -82.7M | -78.7M |
| Net Margin % | 0.0% | 77.0% | -18.0% | -9.6% | -11.4% |
| Key Metrics | |||||
| EBITDA | 5.8M | 59.1M | 114.8M | 107.8M | 19.1M |
| EPS (Basic) | ₹0.21 | ₹24.18 | ₹-8.26 | ₹-4.41 | ₹-4.20 |
| EPS (Diluted) | ₹0.21 | ₹24.18 | ₹-8.26 | ₹-4.41 | ₹-4.20 |
| Basic Shares Outstanding | 18741759 | 18741759 | 18741759 | 18741759 | 18741759 |
| Diluted Shares Outstanding | 18741759 | 18741759 | 18741759 | 18741759 | 18741759 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Fortis Malar Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.0M | 1.1B | 58.6M | 124.0M | 74.3M |
| Short-term Investments | 320.2M | 8.2M | 35.1M | 128.0K | 60.0M |
| Accounts Receivable | - | 0 | 31.8M | 22.0M | 20.9M |
| Inventory | - | 0 | 11.0M | 18.6M | 16.3M |
| Other Current Assets | 15.0K | - | 7.5M | 4.6M | 4.6M |
| Total Current Assets | 341.1M | 1.1B | 844.8M | 490.7M | 599.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 301.1M | 724.6M | 802.2M |
| Goodwill | 0 | 0 | 1.7M | 6.6M | 13.9M |
| Intangible Assets | - | - | 1.7M | 6.6M | 13.9M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | 211.0K | 56.0K | 1.0K |
| Total Non-Current Assets | 27.2M | 25.8M | 535.2M | 1.1B | 1.1B |
| Total Assets | 368.3M | 1.2B | 1.4B | 1.6B | 1.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 43.5M | 52.0M | 202.7M | 200.0M | 143.7M |
| Short-term Debt | - | 0 | 82.2M | 70.2M | 37.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 793.0K | 7.4M | 22.2M | 25.0M | 49.4M |
| Total Current Liabilities | 66.2M | 64.1M | 317.6M | 314.2M | 246.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | 0 | 381.8M | 464.0M | 534.1M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | 1.0K |
| Total Non-Current Liabilities | 0 | 0 | 420.7M | 493.6M | 556.7M |
| Total Liabilities | 66.2M | 64.1M | 738.3M | 807.8M | 803.5M |
| Equity | |||||
| Common Stock | 187.6M | 187.6M | 187.6M | 187.6M | 187.6M |
| Retained Earnings | 18.8M | 811.4M | 358.4M | 518.0M | 604.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 302.1M | 1.1B | 641.7M | 801.3M | 887.4M |
| Key Metrics | |||||
| Total Debt | 0 | 0 | 464.0M | 534.1M | 571.7M |
| Working Capital | 274.9M | 1.1B | 527.2M | 176.5M | 353.0M |
Balance Sheet Composition
Fortis Malar Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 5.7M | 500.1M | -70.1M | -82.6M | -113.1M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 10.9M | 12.9M | -1.3M | -20.3M | -40.0M |
| Operating Cash Flow | -10.6M | -90.5M | -81.4M | -110.0M | -228.9M |
| Investing Activities | |||||
| Capital Expenditures | 0 | -23.0M | -18.8M | -12.8M | -5.3M |
| Acquisitions | 14.6M | 442.6M | 0 | - | - |
| Investment Purchases | -330.5M | - | -34.3M | - | -59.3M |
| Investment Sales | - | - | - | 59.9M | - |
| Investing Cash Flow | -316.0M | 419.6M | -53.0M | -2.9M | -344.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -796.5M | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | -796.5M | - | - | - | - |
| Free Cash Flow | 15.4M | -96.0M | 37.3M | 54.4M | -13.9M |
| Net Change in Cash | -1.1B | 329.2M | -134.4M | -112.9M | -573.5M |
Cash Flow Trend
Fortis Malar Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.60
Price to Book
3.10
Price to Sales
2,230.27
PEG Ratio
0.00
Profitability Ratios
Profit Margin
9,464.38%
Operating Margin
-13,260.00%
Return on Equity
1.30%
Return on Assets
1.06%
Financial Health
Current Ratio
12.24
Debt to Equity
0.00
Beta
0.06
Per Share Data
EPS (TTM)
₹2.42
Book Value per Share
₹18.40
Revenue per Share
₹0.02
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| FORTISMLR | 1.1B | 23.60 | 3.10 | 1.30% | 9,464.38% | 0.00 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Indraprastha Medical | 37.3B | 20.08 | 5.57 | 26.98% | 12.60% | 4.76 |
| Dr. Agarwal's Eye | 24.3B | 34.01 | 7.52 | 26.07% | 15.50% | 106.45 |
| Shalby | 16.7B | 207.28 | 1.75 | 0.63% | 0.72% | 53.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.




